BACKGROUND: -Type 2 diabetes is an independent risk factor for heart failure development, but the relationship between incident heart failure and antecedent glycaemia has not been evaluated.
METHODS AND RESULTS: -The Go-DARTS study holds data for 8683 individuals with type 2 diabetes. Dispensed prescribing, hospital admission data and echocardiography reports were linked to extract incident heart failure cases from December 1998 to August 2011. All available HbA1c measures until heart failure development or end of study were used to model HbA1c time-dependently. Individuals were observed from study enrolment until heart failure development or end of study. Proportional hazard regression calculated heart failure development risk associated with specific HbA1c ranges accounting for comorbidities associated with heart failure, including blood pressure, body mass index and coronary artery disease. Seven hundred and one individuals with type 2 diabetes (8%) developed heart failure during follow up (mean 5.5 years, ±2.8 years). Time-updated analysis with longitudinal HbA1c showed that both HbA1c <6% (HR = 1.60, 95% CI 1.38-1.86 P-value= <0.0001) as well as HbA1c> 10% (HR = 1.80, 95% CI 1.60-2.16 P-value= <0.0001) were independently associated with the risk of HF.
CONCLUSIONS: -Both high and low HbA1c predicted heart failure development in our cohort, forming a U-shaped relationship.
|Number of pages||7|
|Journal||Circulation: Heart Failure|
|Early online date||5 Jan 2015|
|Publication status||Published - Mar 2015|